Notice: Prescription Drug List (PDL): Vitamin D
Description
The purpose of this Notice of Amendment is to notify that Health Canada has revised the listing of Vitamin D on the Prescription Drug List (PDL) to allow non-prescription status for products a) containing up to 62.5 µg or 2,500 International Units (IU)/dosage form for oral use; or b) with a maximum recommended daily oral intake of 2,500 IU. Only the Human part of the PDL was revised.
Resources
| Name |
Format |
Description |
Link |
| Notice: Prescription Drug List (PDL): Vitamin D |
HTML |
|
https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notices-changes/notice-amendment-vitamin-d.html |
| Notice: Prescription Drug List (PDL): Vitamin D |
HTML |
|
https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/medicaments/liste-drogues-ordonnance/avis-concernant-modifications/avis-modification-vitamine-d.html |